236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1-3 June 2018

Wong SC, Straub V, Ward LM, Quinlivan R, th Ewp. 236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1-3 June 2018. Neuromuscular disorders : NMD 2019;29:251-259

Wong_2019_Neuromuscul Disord. Jan 12

Introduction

On 1–3 June 2018, the 236th European Neuromuscular Centre workshop was held in Hoofddorp, The Netherlands, to discuss the issue of bone protective therapies in Duchenne muscular dystrophy (DMD), in particular, the feasibility of developing clinical trials. Twenty-six delegates, that included 19 experts in the neuromuscular and bone clinical and research fields, three representatives from patient organizations, two adults with DMD and two representatives from industry, attended this workshop.

search previous next tag category expand menu location phone mail time cart zoom edit close